fingolimod mylan
mylan ireland limited - fingolimod vesinikkloriid - sclerosis multiplex, relapsing-remitting - immunosupressandid - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ja 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
zeposia
bristol-myers squibb pharma eeig - ozanimod vesinikkloriid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosupressandid - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
ponvory
janssen-cilag international n.v. - ponesimod - sclerosis multiplex, relapsing-remitting - immunosupressandid - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
tysabri
biogen netherlands b.v. - natalisumab - hulgiskleroos - selektiivsed immunosupressandid - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 ja 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
tyruko
sandoz gmbh - natalisumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 ja 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
foclivia
seqirus s.r.l. - inaktiveeritud gripiviiruse pinnaantigeenid: a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - gripivaktsiinid - gripi profülaktika ametlikult pandeemia korral. pandeemilise gripi vaktsiini tuleks kasutada vastavalt ametlikele juhistele.
inzolfi kõvakapsel
sandoz pharmaceuticals d.d. - fingolimood - kõvakapsel - 0,25mg 28tk
methotrexate ebewe 100 mg/ml infusioonilahuse kontsentraat
sandoz pharmaceuticals d.d. - metotreksaat - infusioonilahuse kontsentraat - 100mg 1ml 5ml 5tk; 100mg 1ml 10ml 1tk; 100mg 1ml 5ml 1tk; 100mg 1ml 50ml 5tk; 100mg 1ml 10ml 5tk
methotrexate ebewe 100 mg/ml infusioonilahuse kontsentraat
first pharma oÜ - metotreksaat - infusioonilahuse kontsentraat - 100mg 1ml 50ml 1tk
methotrexate ebewe 100 mg/ml infusioonilahuse kontsentraat
ideal trade links uab - metotreksaat - infusioonilahuse kontsentraat - 100mg 1ml 50ml 1tk